Humana マネジメント

マネジメント基準チェック /24

Humanaの CEO はJim Rechtinで、 Jan2024年に任命され、の在任期間は 1 年未満です。は、会社の株式の0%を直接所有しており、その価値はR$ 20.58K 。経営陣と取締役会の平均在任期間はそれぞれ2.3年と4年です。

主要情報

Jim Rechtin

最高経営責任者

n/a

報酬総額

CEO給与比率	n/a
CEO在任期間	less than a year
CEOの所有権	0.00001%
経営陣の平均在職期間	2.3yrs
取締役会の平均在任期間	4yrs

経営陣の近況

Recent updates

CEO（最高経営責任者

Jim Rechtin (53 yo)

less than a year

在職期間

Mr. James A. Rechtin, also known as Jim, MBA, served as COO of Humana Inc. since January 08, 2024 until July 01, 2024 and serves as its President since January 08, 2024 and also serves as its Chief Executi...

リーダーシップ・チーム

名称	ポジション	在職期間	報酬	所有権
Susan Diamond	Chief Financial Officer	3.4yrs	US$4.73m	0.0072% R$ 14.8m
Joseph Ventura	Chief Legal Officer	5.8yrs	US$3.10m	0.0060% R$ 12.4m
Bruce Broussard	Strategic Advisor	less than a year	US$16.33m	0.073% R$ 151.0m
George Renaudin	President of Medicare & Medicaid	1.8yrs	US$3.11m	0.0032% R$ 6.5m
Sanjay Shetty	President of CenterWell	1.7yrs	US$4.58m	0.00014% R$ 288.1k
James Rechtin	President	less than a year	データなし	0.000010% R$ 20.6k
John-Paul Felter	Senior VP	2.3yrs	データなし	0.00031% R$ 637.9k
Eric Tagliere	Senior VP & CTO	less than a year	データなし	データなし
Samir Deshpande	Chief Information Officer	3.8yrs	データなし	0.010% R$ 21.2m
Timothy Huval	Chief Administrative Officer	5.3yrs	US$3.73m	0.0061% R$ 12.6m
Lisa Stoner	Vice President of Investor Relations	no data	データなし	データなし
Vishal Agrawal	Chief Strategy & Corporate Development Officer	5.9yrs	データなし	0.0090% R$ 18.6m

2.3yrs

平均在職期間

51.5yo

平均年齢

経験豊富な経営陣: H1UM34の経営陣は経験豊富であると考えられます ( 2.3年の平均在職年数)。

取締役

名称	ポジション	在職期間	報酬	所有権
James Rechtin	President	less than a year	データなし	0.000010% R$ 20.6k
Kurt Hilzinger	Independent Chairman of the Board	21.3yrs	US$601.30k	0.016% R$ 33.2m
Karen Katz	Independent Director	5.2yrs	US$346.55k	0.00049% R$ 1.0m
Frank D'Amelio	Independent Director	21.2yrs	US$363.55k	0.017% R$ 35.3m
Jorge Mesquita	Independent Director	3.8yrs	US$351.59k	0.0018% R$ 3.7m
Brad Smith	Independent Director	2.2yrs	US$311.07k	0.00032% R$ 658.5k
Wayne Frederick	Independent Director	4.8yrs	US$364.87k	0.00037% R$ 761.3k
David Feinberg	Independent Director	2.7yrs	US$321.52k	0.00037% R$ 761.3k
Marcy Klevorn	Independent Director	3.8yrs	US$351.94k	0.00036% R$ 740.8k
John Garratt	Independent Director	4.8yrs	US$326.03k	0.0010% R$ 2.1m
RaQuel Bono	Independent Director	4.2yrs	US$345.03k	0.00033% R$ 679.0k
Gordon Smith	Independent Director	less than a year	データなし	データなし

4.0yrs

平均在職期間

62yo

平均年齢

経験豊富なボード: H1UM34の取締役会は経験豊富であると考えられます ( 4年の平均在任期間)。

Humana マネジメント

マネジメント 基準チェック /24

主要情報

経営陣の近況

Humana Inc. Appoints Michelle O'hara as Chief Human Resources Officer, Effective January 1, 2025

Humana Elects Gordon Smith to Board of Directors

Humana Inc., Annual General Meeting, Apr 18, 2024

Humana Inc., Annual General Meeting, Apr 18, 2024

Humana Inc. Announces Management Changes

Humana Inc. Announces Management Changes

Recent updates

Humana Inc. Appoints Michelle O'hara as Chief Human Resources Officer, Effective January 1, 2025

Humana Inc. Updates Earnings Guidance for the Year Ending December 31, 2024

Humana Inc. Declares Payment of Quarterly Dividend to Stockholders, Payable on January 31, 2025

Humana Elects Gordon Smith to Board of Directors

Humana Inc. to Report Q3, 2024 Results on Oct 30, 2024

Humana Settles for $90 Million Groundbreaking False Claims Act Case Alleging Medicare Part D Prescription Drug Program Fraud

Humana Inc. Declares Cash Dividend, Payable on October 25, 2024

Humana Inc. Revises Earnings Guidance for the Year Ending December 31, 2024

Humana Inc. to Report Q2, 2024 Results on Jul 31, 2024

Gainey Mckenna & Egleston Announces a Class Action Lawsuit Has Been Filed Against Humana, Inc

Humana Inc. Revises Earnings Guidance for the Year Ending December 31, 2024

Humana Inc. Declares Cash Dividend, Payable on July 26, 2024

Humana Inc. to Report Q1, 2024 Results on Apr 24, 2024

Humana Inc., Annual General Meeting, Apr 18, 2024

Humana Inc., Annual General Meeting, Apr 18, 2024

Humana Inc. Declares Cash Dividend, Payable on April 26, 2024

Humana Inc. Provides Earnings Guidance for 2024

Humana Announces Limited Layoffs

Cigna Reportedly Ends Humana Merger Talks

Cigna, Humana Reportedly in Talks for Merger

Humana Inc. Declares Cash Dividend, Payable on January 26, 2024

Humana Inc. Announces Management Changes

Humana Inc. Announces Management Changes

Humana Inc. to Report Q3, 2023 Results on Nov 01, 2023

Humana Inc. (NYSE:HUM) agreed to acquire Senior-focused primary care centers in Texas and Nevada of Cano Health, LLC for $66.7 million.

Centerwell Senior Primary Care Introduces In-Home Primary Care

Humana Inc. Declares Cash Dividend, Payable on October 27, 2023

Humana Inc. Revises Earnings Guidance for the Year Ending December 31, 2023

Humana Inc. to Report Q2, 2023 Results on Aug 02, 2023

Humana Inc. Declares Cash Dividend, Payable on April 28, 2023

Humana Inc. Provides Earnings Guidance for the Fiscal Year Ending December 31, 2023

Humana Inc. to Report Q4, 2022 Results on Feb 01, 2023

Humana Inc. Provides Earning Guidance for Fiscal Year 2022

Humana Inc. Declares Cash Dividend to Stockholders, Payable on January 27, 2023

Humana, USAA Launch New Medicare Advantage Plan Tailored to Veterans’ Needs

Humana Inc. to Report Q3, 2022 Results on Nov 02, 2022

Humana Reportedly Among Firms Looking to Buy Cano Health

Humana Elects Brad D. Smith to Board of Directors

Humana Inc. Declares Payment of Quarterly Dividend to Stockholders, October 28, 2022

Humana Inc. (NYSE:HUM) agreed to acquire Substantially All of the Assets of Inclusa, Inc.

Humana Inc. Reports Impairment Charges for the Second Quarter Ended June 30, 2022

Humana Inc. to Report Q2, 2022 Results on Jul 27, 2022

Humana Inc. Announces Management Changes

Humana Inc. Declares Payment of Quarterly Dividend to Stockholders, Payable on July 29, 2022

Humana Inc. to Report Q1, 2022 Results on Apr 27, 2022

Humana Inc. Announces Executive Changes, Effective March 31, 2022

Humana Board Declares Payment of Quarterly Dividend to Stockholders, Payable on April 29, 2022

Humana Inc. Provides Earnings Guidance for the Year Ending December 31, 2022

Humana Inc. (NYSE:HUM) completed the acquisition of the remaining 60% stake in Kindred Healthcare, LLC from TPG Capital, L.P., and Welsh, Carson, Anderson & Stowe.

Humana Inc.(NYSE:HUM) dropped from Russell 1000 Growth Index

Humana Pharmacy Moves to Sustainable Packaging for Temperature-Sensitive Shipments

Humana Inc. (NYSE:HUM) signed a definitive agreement to acquire One Homecare Solutions Llc from Waypoint Capital Partners, LLC.

Humana Inc. Revises Earnings Guidance for the Year Ending December 31, 2021

Humana Inc., Annual General Meeting, Apr 22, 2021

Bio-Techne's Exosome Diagnostics Laboratory Announces Reimbursement Contract with Humana

Humana Military Names Alefiyah Mesiwala as its New Chief Medical Officer, Effective March 15

Mercy and Humana Team Up to Expand Access to Virtual Health Services and Coordinated Care

Humana Announces Board Changes

Humana Launches Humana Care Support Pilot to Help Medicare Advantage Members to Better Manage Their Chronic Conditions

Humana Begins Coverage of Hospice Services as Part of Medicare Demonstration

Sanford Heisler Sharp, LLP Announces Roche Diagnostics Corp. and Roche Diabetes Care, Inc. and Humana, Inc., Humana Pharmacy, Inc., and Humana Pharmacy Solutions, Inc. Have Agree to Settle False Claims Act Lawsuit Brought by Whistleblower Relator on Behalf of the United States

Oklahoma Health Care Authority Selects Humana Inc. to Serve Medicaid Beneficiaries

the South Carolina Department of Health and Human Services Adds Humana Inc. to its Healthy Connections Medicaid Program and Its Healthy Connections Prime Program

Humana Names Nwando Olayiwola, M.D., Chief Health Equity Officer

athenahealth and Humana Collaborate to Improve Healthcare Outcomes for Its Members

Humana Inc. Partners with Leading Ohio Nonprofits to Address Food Insecurity and Housing

Humana Inc. Announces New Primary Care Value-Based Model

Huntington’s St. Mary’s Medical Center and Humana Announce Medicare Network Agreement

Humana Inc. (NYSE:HUM) agreed to acquire the remaining 50% stake in Independent Care Health Plan from Centers For Independence Inc.

マネジメント基準チェック /24